Berberine In The Treatment Of Type 2 Diabetes Mellitus: A Systemic Review And Meta-analysis
| Effect | Decrease |
| Trial Design | Meta analysis |
| Trial Length | n/a |
| Number of Subjects | 1068 |
| Sex | n/a |
In diabetic patients, Berberine at 0.5-1.5g daily for an average period of 12 weeks was associated with minor to moderate improvements on all measured glucose and lipid parameters; rivalling oral hypoglycemics in potency
